Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA[R] (tapinarof) Cream, 1%

The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. JERSEY CITY, N.J. -- Organon (NYSE: OGN), a global healthcare company with a mission to [...]